The influence of two policies of closure of the laparotomy wound in the rate of surgical site infection in colorectal cancer surgery: the New Operation trial

ISRCTN ISRCTN19463413
DOI https://doi.org/10.1186/ISRCTN19463413
Secondary identifying numbers 09/01; PI08/90196
Submission date
15/05/2009
Registration date
17/06/2009
Last edited
05/04/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Hector Ortiz
Scientific

Hospital Virgen del Camino
Irunlarrea 4
Pamplona
31008
Spain

Phone +34 65 98 67 210
Email hortizhu@cfnavarra.es

Study information

Study designProspective double blinded randomised multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA prospective double blinded randomised multicentre trial of the influence of two policies of closure of the laparotomy wound in the rate of surgical site infection in colorectal cancer surgery
Study acronymNewOp
Study objectivesA decreased faecal load in the surgical wound diminished the incidence of surgical site infection.
Ethics approval(s)The Medical Ethics Committee of the Virgen del Camino Academic Medical Centre, Pamplona gave approval on the 7th May 2009 (ref: 6/2008). Under Spanish law, all other centres will be included under this approval.
Health condition(s) or problem(s) studiedColorectal cancer
InterventionControl group: at the end of the operation the nurses and surgeons will change gloves, a new set of surgical instruments will be used and the surgical drapes surrounding the laparotomy will be changed.

Study group: at the end of the operation and before closing the laparotomy; the surgical assistant will retire all the surgical drapes and the surgeon will retire the plastic coverage of the wound and the wound will be covered with a povidone-soaked gauze. Nurse and surgical teams will scrub again and the surgical instruments will be changed.

Total duration of follow-up: one month after the recruitment of the last patient.
Intervention typeOther
Primary outcome measureIncidence of surgical site infection. The criteria to define surgical site infection are described by Disease Control and Prevention National Healthcare Safety Network (Spain). For the purposes of this study superficial and deep wound infections would be considered as a unique entity condition. This will be measured 30 days after the operation.
Secondary outcome measuresThe relationship between wound infection rate and the following variables:
1. Age
2. Sex
3. Location of the tumour (colon/rectum)
4. TNM stage
5. Obesity
6. Level of glucose
7. Long course radiotherapy

Measured 30 days after the operation.
Overall study start date01/06/2009
Completion date01/06/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants738
Key inclusion criteria1. Aged above 18 years, either sex
2. Colon and rectal cancer
Key exclusion criteria1. Before the enrolment: emergency surgery
2. At enrolment:
2.1. Not willing to participate
2.2. Non-resectable tumours
2.3. Multi-visceral resection planned
2.4. Recurrence of colon or rectal carcinoma
2.5. Laparoscopic abdominoperineal resection
2.6. Patients programmed to place a mesh simultaneously for an incisional hernia
3. At allocation:
3.1. Non-resectable tumours
3.2. The surgeon decides to prescribe antibiotics due to faecal contamination during operation
3.3. Any violation of the protocol
4. At follow-up:
4.1. Peri-operative mortality
4.2. Patients reoperated for any reason in the first 30 days after primary surgery
4.3. Patients with an organ/space infection draining through the wound
4.4. Patients not followed for at least 30 days after surgery
Date of first enrolment01/06/2009
Date of final enrolment01/06/2011

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Virgen del Camino
Pamplona
31008
Spain

Sponsor information

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Research organisation

C/ Sinesio Delgado 4 - 6 (entrada por Avda. Monforte de Lemos, 5.)
Madrid
28029
Spain

Email Registro.general@isciii.es
Website http://www.isciii.es/htdocs/index.jsp
ROR logo "ROR" https://ror.org/00ca2c886

Funders

Funder type

Research council

Spanish National Research Council (Consejo Superior de Investigaciones Cientificas [CSIC]) (Spain)
Government organisation / National government
Alternative name(s)
Spanish National Research Council, El Consejo Superior de Investigaciones Científicas (CSIC), CSIC, elcsic
Location
Spain

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2012 Yes No